GlobalData: Ventilator industry prepares for second wave of COVID-19 outbreaks

NewsGuard 100/100 Score

Following reports that the second wave of COVID-19 is almost inevitable towards the winter, the ventilator industry is working with government and third-party partners to prepare for the potential shortage. GlobalData expects the market will reach $5.2bn by end of 2020, expanding more than four times compared to 2019.

Prior to the COVID-19 pandemic, the global ventilators market was valued at $1.1bn in 2019, growing at an annual rate of 3.5%. The COVID-19 pandemic was initially typified with worldwide calls for more ventilators. However, as the pandemic has progressed and clinical knowledge has improved, the actual usage of ventilators has differed from projections.”

Tina Deng, MSc, Senior Medical Devices Analyst at GlobalData

If COVID-19 cases surge during the second wave, demand for ventilators could increase again. The European Commission (EC) signed framework contracts with Philips to supply medical ventilators to EU hospitals, while Celestica and Starfish recently signed a contract to provide 7,500 more ventilators to Health Canada in Q4 2020. In addition, wearable devices maker Fitbit plans to shift its supply chain to make emergency-use ventilators and Foxcoon Technology Group recently completed the regulatory requirements to manufacture 10,000 Medtronic Puritan Bennett 560 ventilators over 2021.

The Foxcoon and Medtronic cooperation indicates a sign of shifting relationships in the OEM, but also shows that the industry has taken precaution about the second wave of COVID-19.”

Tina Deng, MSc



The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative COVID-19 test prototype uses bioluminescence for speedier results